Inhibition of mTOR Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy
Autor: | Xiao-Sa Chi, Wei Wang, Cheng Huang, Mengqian Wu, Jin-Mei Li, Rui Li, Dong Zhou |
---|---|
Rok vydání: | 2017 |
Předmět: |
Adult
Male 0301 basic medicine Phenytoin Drug Resistant Epilepsy medicine.medical_specialty Neurology Pharmacology Rats Sprague-Dawley Lactones 03 medical and health sciences Cellular and Molecular Neuroscience Epilepsy 0302 clinical medicine Seizures Animals Humans Medicine ATP Binding Cassette Transporter Subfamily B Member 1 PI3K/AKT/mTOR pathway P-glycoprotein Sirolimus Temporal cortex biology business.industry TOR Serine-Threonine Kinases General Medicine medicine.disease Rats Blot 030104 developmental biology Case-Control Studies biology.protein Immunohistochemistry Anticonvulsants Female business 030217 neurology & neurosurgery medicine.drug |
Zdroj: | Journal of Molecular Neuroscience. 61:553-562 |
ISSN: | 1559-1166 0895-8696 |
Popis: | The mammalian target of rapamycin (mTOR) has been demonstrated to mediate multidrug resistance in various tumors by inducing P-glycoprotein (P-gp) overexpression. Here, we investigated the correlation between the mTOR pathway and P-gp expression in pharmacoresistant epilepsy. Temporal cortex specimens were obtained from patients with refractory mesial temporal lobe epilepsy (mTLE) and age-matched controls who underwent surgeries at West China Hospital of Sichuan University between June 2014 and May 2015. We established a rat model of epilepsy kindled by coriaria lactone (CL) and screened pharmacoresistant rats (non-responders) using phenytoin. Non-responders were treated for 4 weeks with vehicle only or with the mTOR pathway inhibitor rapamycin at doses of 1, 3, and 6 mg/kg. Western blotting and immunohistochemistry were used to detect the expression of phospho-S6 (P-S6) and P-gp at different time points (1 h, 8 h, 1 day, 3 days, 1 weeks, 2 weeks, and 4 weeks) after the onset of treatment. Overexpression of P-S6 and P-gp was detected in both refractory mTLE patients and non-responder rats. Rapamycin showed an inhibitory effect on P-S6 and P-gp expression 1 week after treatment in rats. In addition, the expression levels of P-S6 and P-gp in the 6 mg/kg group were significantly lower than those in the 1 mg/kg or the 3 mg/kg group at the same time points (all P |
Databáze: | OpenAIRE |
Externí odkaz: |